用于评估肝硬化患者静脉曲张与门体分流的标准CT协议的验证
该回顾性队列研究纳入184例晚期慢性肝病患者的CT资料,提出并验证用于评估所有类型门体侧支循环的标准CT协议,并构建影像学评分预测肝硬化患者失代偿风险。肝硬化患者标准CT协议对门体侧支的检测与测量具有优异的观察者内和观察者间一致性,基于门体分流、脾直径>16 cm、门静脉直径>17 mm及腹水的评分可将5年失代偿风险分为低、中、高三层。
要点
- 标准CT协议对几乎所有类型门体侧支的检测与测量观察者内和观察者间一致性均优异。
- 门体分流、脾直径>16 cm、门静脉直径>17 mm及腹水为无失代偿生存的独立预测因素。
- 影像学评分可将肝硬化患者5年失代偿风险分为低(11.3%)、中(35.6%)、高(70.8%)。
核心结论
- 用于肝硬化患者HCC监测项目的常规CT协议对检测所有类型门体侧支循环是有效的;所识别的预测无失代偿生存的影像学评分可能成为易用的临床工具。
研究设计与样本
- 回顾性队列研究,纳入184例晚期慢性肝病患者的CT资料;排除影像、弹性成像、内镜及生化评估间隔>6个月者、既往TIPS或肝移植者及终末期医疗状况者;基线及注射对比剂后采用多期技术及团注追踪扫描;由两个不同中心的两名资深放射科医生和一名非专家放射科医生审阅所有CT检查以评估观察者内和观察者间变异及外部验证;采用单变量及校正多变量竞争风险回归模型分析影像学变量。
关键影像表现/征象
- CT可检测并测量所有类型门体侧支(P-SC),包括胃食管静脉曲张和自发性门体分流(SPSS),观察者内和观察者间一致性均优异。
- 自发性门体分流(SPSS)的存在、脾直径>16 cm、门静脉直径>17 mm及腹水的存在为肝硬化患者无失代偿生存的独立预测因素。
诊断标准与关键数值
- 影像学评分包含SPSS存在、脾直径>16 cm、门静脉直径>17 mm及腹水存在,AUROC=0.799,p-value=0.732。
- 评分将5年失代偿风险分为低(11.3%)、中(35.6%)、高(70.8%)。
临床应用与阅片要点
- 肝硬化患者HCC监测项目中常规执行的CT协议可用于检测所有类型门体侧支循环。
- 作者认为,所识别的预测无失代偿生存的影像学评分可能成为易用的临床工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of the present study was to propose and validate a standardized CT protocol for evaluating all the types of portosystemic collaterals (P-SC), including gastroesophageal varices and spontaneous portosystemic shunts (SPSS), and to evaluate the prognostic role of portal hypertension CT features for the prediction of the hepatic decompensation risk in cirrhotic patients.
METHODS: A retrospective cohort study of 184 advanced chronic liver disease who underwent CT scan between January 2014 and December 2017. Patients with an interval > 6 months between the imaging, elastometric, endoscopic and biochemical evaluation were excluded, as well as patients with previous transjugular intrahepatic portosystemic shunt (TIPS), liver transplantation (LT) or terminal medical conditions. Data on liver disease history, co-morbidities, endoscopic and radiologic findings were collected. The incidence of hepatic decompensation and other events, such as portal vein thrombosis, HCC, TIPS placement, LT, death, and its cause, were also recorded. The procedure was performed at baseline and after the administration of contrast agent using a multiphasic technique and bolus tracking. Two senior radiologists working in different centres and a non-expert radiologist reviewed all CT examinations, to evaluate both intra-observer and inter-observer variability of the CT protocol and to obtain an external validation. The radiological variables were evaluated using both univariate and adjusted multivariate competing risk regression models.
RESULTS: Both intra-observer and inter-observer agreement were excellent in detection and measurement of almost all types of P-SC. The presence of SPSS, a spleen diameter > 16 cm, a portal vein diameter > 17 mm and the presence of ascites resulted independent predictors of decompensation-free survival for cirrhotic patients and were incorporated in an easy-to-use score (AUROC = 0.799, p-value = 0.732) which can the risk of decompensation at 5 years, ranking it as low (11.3%), moderate (35.6%) or high (70.8%).
CONCLUSIONS: The CT protocol commonly performed during the HCC surveillance program for cirrhotic patients is valid for detecting all types of P-SC. The radiological score identified to predict the decompensation-free survival for cirrhotic patients could be an easy-to-use clinical tool.
引用
- Renzulli M, Dajti E, Ierardi AM, et al. Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients. Eur J Radiol. 2021. PMID: 34801322. doi:10.1016/j.ejrad.2021.110010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。